Bioventus amends stockholders agreement to phase out classified board structure

Bioventus Inc.

Amendment to Stockholders Agreement moves to annual director elections after 2024 annual meeting.
Existing three-year terms for current directors continue until expiration; successors will serve one-year terms.
Company authorized to amend charter and bylaws to reflect declassification of the Board.
Change applies to director designees of Essex and S+N principal stockholders.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.